Philip Ron M bought AVTX
September 30, 2026 · Form 4 insider transaction
Philip Ron M bought 1,109 shares of Avalo Therapeutics, Inc. at $12.29 per share, a transaction worth $13.6K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,109
Price
$12.29
Total value
$13.6K
InsiderPhilip Ron M
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 30, 2026
Filing dateOctober 2, 2026
Shares owned after1,109
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options were issued to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Plan in lieu of Board fees.; The options were granted on September 30, 2026, and are 100% vested.